Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $145M invested in Harvard Bioscience in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% more capital invested
Capital invested by funds: $143M → $145M (+$2.22M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
94
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.68M | |
| 3 | +$1.34M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.02M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$922K |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.5M | |
| 3 | -$1.33M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$791K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$650K |